Pediatr Blood Cancer: The Effectiveness of Neutlyte Cell Reduction Diet and Food Safety Guidelines for Infection Rates in Pediatric Tumor Patients

The neutrophil diet (ND) is designed to prevent bacteria from entering the host's gastrointestinal tract and reduce infectionIn the absence of evidence to support ND, pediatric oncologists are still debating the usefulness of NDThis prospective randomized controlled trial assessed the difference in neutrophil infection rates in pediatric tumor patients who were randomly accepted by the Food and Drug Administration approved by the Food and Drug Administration (FSG) and ND plus FSG during a cycle of chemotherapyChildren with pediatric tumorsmet with treatment for marrow-inhibitive chemotherapyNeutlyte-to-cell hyperplasia infection is the main result, defined as (i) fever with neutoflodosis or (ii) hospitalization for clinical infection and neutoflodosisThe rate of neutrophil hyperplasia infection was compared with a Student's t test in a separate sampleThe recorded infection was determined through a comprehensive medical record review, and the inter-group was compared using the test of s2results showed that 150 patients were randomly assigned to FSG (n s 73) or ND-FSG (n -77)The most common diagnoses are acute lymphoblastic leukemia (32%) and sarcoma (32%)There was no significant difference in the proportion of neutrophil infections in the two groupsFSGs 33% vsND and FSGs 35% (P - 0.78)Patients randomly added to ND-FSGs reported that following diettherapy required more effort than those who took FSGs alone, the results show that ND has no benefit than FSG in preventing infection in pediatric tumor patients undergoing bone marrow-inhibited chemotherapy, and patients and their families need to work harder to stay onInstitutions caring for children with cancer should consider replacing ND guidelines with anti-inflammatory guidelines